Electronic cigarettes: overview of chemical composition and exposure estimation

Tobacco Induced Diseases

Dirk W Lachenmeier³  Thomas Kuballa³  Harald Hahn²  Jörg Schüssler³  Matthias Kohl-Himmelseher³  Julia Hengen³  Yulia B Monakhova¹  Jürgen Hahn² 

[1] Bruker Biospin GmbH, Silberstreifen, Rheinstetten, 76287, Germany;Chemisches und Veterinäruntersuchungsamt (CVUA) Sigmaringen, Fidelis-Graf-Straße 1, Sigmaringen, 72488, Germany;Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, Karlsruhe, 76187, Germany

关键词: Risk assessment;    Nicotine;    Electronic nicotine delivery systems;    Electronic cigarettes;   

Others  :  1130870
DOI  :  10.1186/s12971-014-0023-6

 received in 2014-05-23, accepted in 2014-11-13,  发布年份 2014

【 摘 要 】

Background

Electronic cigarettes (e-cigarettes) are advertised to tobacco users as a tool to decrease cigarette consumption and to reduce toxic exposure associated with conventional tobacco smoking. Little is known about the compounds contained in such products, their exposure and long-term health effects.

Methods

NMR spectroscopy was used to ascertain the content of several constituents of e-cigarette liquids including nicotine, solvents and some bioactive flavour compounds. Risk assessment was based on probabilistic exposure estimation and comparison with toxicological thresholds using the margin of exposure (MOE) approach.

Results

In 54 samples of e-cigarette liquids, the average nicotine content was 11 mg/ml. Only 18 from 23 samples were confirmed as nicotine-free samples and in one e-cigarette liquid nicotine was not detected while being declared on the labelling. Major compounds of e-cigarette liquids include glycerol (average 37 g/100 g), propylene glycol (average 57 g/100 g) and ethylene glycol (average 10 g/100 g). Furthermore, 1,3-propanediol, thujone and ethyl vanillin were detected in some samples. The average exposure for daily users was estimated as 0.38 mg/kg bw/day for nicotine, 8.9 mg/kg bw/day for glycerol, 14.5 mg/kg bw/day for 1,2-propanediol, 2.1 mg/kg bw/day for ethylene glycol, and below 0.2 mg/kg bw/day for the other compounds. The MOE was below 0.1 for nicotine, but all other compounds did not reach MOE values below 100 except ethylene glycol and 1,2-propanediol.

Conclusions

NMR spectroscopy is a useful and rapid method to simultaneously detect several ingredients in e-cigarette liquids. From all compounds tested, only nicotine may reach exposures that fall into a high risk category with MOE <1. Therefore, e-cigarette liquid products should be subjected to regulatory control to ensure consistent nicotine delivery. Solvents with more favourable toxicological profiles should be used instead of ethylene glycol and 1,2-propanediol, which may fall into a risk category with MOE < 100.

【 授权许可】

   
2014 Hahn et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Yamin CK, Bitton A, Bates DW: E-cigarettes: a rapidly growing internet phenomenon. Ann Intern Med 2010, 153:607-609.
• [2]Regan AK, Promoff G, Dube SR, Arrazola R: Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA. Tob Control 2011, 22:19-23.
• [3]Farsalinos KE, Romagna G, Allifranchini E, Ripamonti E, Bocchietto E, Todeschi S, Tsiapras D, Kyrzopoulos S, Voudris V: Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013, 10:5146-5162.
• [4]Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE: Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 2013, 25:354-361.
• [5]Odum LE, O’Dell KA, Schepers JS: Electronic cigarettes: do they have a role in smoking cessation? J Pharm Pract 2012, 25:611-614.
• [6]Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE: A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemol Biomarkers Prev 2010, 19:1945-1953.
• [7]Flouris AD, Poulianiti KP, Chorti MS, Jamurtas AZ, Kouretas D, Owolabi EO, Tzatzarakis MN, Tsatsakis AM, Koutedakis Y: Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 2012, 50:3600-3603.
• [8]Trtchounian A, Williams M, Talbot P: Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2013, 12:905-912.
• [9]Foulds J, Veldheer S, Berg A: Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract 2011, 65:1037-1042.
• [10]Laugesen M: Safety Report on the Ruyan E-cigarette Cartridge and Inhaled Aerosol. Health New Zealand Ltd, Christchurch, New Zealand; 2008.
• [11]Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C: Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011, 11:786. BioMed Central Full Text
• [12]Lindsay JC: Technical Review and Analysis of FDA Report: “Evaluation of E-cigarettes”. Exponent Health Sciences, Houston, TX, USA; 2009.
• [13]Trehy ML, Ye W, Handwiger ME, Moore TW, Allgire JF, Woodruff JT, Ahadi SS, Black JC, Westenberger BJ: Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chrom Rel Technol 2011, 34:1442-1458.
• [14]Thomas B: Njoy Study to Determine Presence of TSNAs in Njoy Vapor. Ben Thomas Group , LLC, Houston, TX, USA; 2009.
• [15]Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger BJ: Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A 2010, 1217:7547-7555.
• [16]Alliance Technologies: Characterization of Regal Cartridges for Electronic Cigarettes - Phase II. Alliance Technologies, Monmouth Junction, NJ, USA; 2009.
• [17]Etter JF, Zather E, Svensson S: Analysis of refill liquids for electronic cigarettes. Addiction 2013, 108:1671-1679.
• [18]Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L: Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013, 15:158-166.
• [19]Goniewicz ML, Hajek P, McRobbie H: Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 2014, 109:500-507.
• [20]Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Peyton IJ, Benowitz N: Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014, 23:133-139.
• [21]Monakhova YB, Kuballa T, Löbell-Behrends S, Maixner S, Kohl-Himmelseher M, Ruge W, Lachenmeier DW: Standardless 1H NMR determination of pharmacology active substances in dietary supplements and medicines that have been illegaly traded over the Internet. Drug Test Anal 2012, 5:400-411.
• [22]Maes P, Monakhova YB, Kuballa T, Reusch H, Lachenmeier DW: Qualitative and quantitative control of carbonated cola beverages using 1H NMR spectroscopy. J Agric Food Chem 2012, 60:2778-2784.
• [23]BfR: Liquids from E-cigarettes can be Detrimental to Health. BfR Opinion No. 016/2012. Federal Institute for Risk Assessment, Berlin, Germany; 2012.
• [24]Lachenmeier DW, Breaux TA, Kuballa T, Schlee C, Monakhova YB: Composition of distilled Perique tobacco liqueur: a connoisseur’s spirit or a health risk due to nicotine? Food Chem 2014, 159:230-235.
• [25]German Institute for Standardization: DIN 32 645. Chemical Analysis - Decision Limit, Detection Limit and Determination Limit Under Repeatability Conditions - Terms, Methods, Evaluation. Beuth Verlag, Berlin, Germany; 2008.
• [26]Lachenmeier DW, Przybylski MC, Rehm J: Comparative risk assessment of carcinogens in alcoholic beverages using the margin of exposure approach. Int J Cancer 2012, 131:E995-E1003.
• [27]Lachenmeier DW, Rehm J: Unrecorded alcohol - no worries besides ethanol: a population-based probabilistic risk assessment. In Alcohol Policy in Europe: Evidence from AMPHORA. 2nd edition. Edited by Anderson P, Braddick F, Reynolds J, Gual A. Alcohol Measures for Public Health Research Alliance (AMPHORA), Barcelona, Spain; 2013:118-130.
• [28]Lachenmeier DW, Godelmann R, Witt B, Riedel K, Rehm J: Can resveratrol in wine protect against the carcinogenicity of ethanol? A probabilistic dose–response assessment. Int J Cancer 2014, 134:144-153.
• [29]Lachenmeier DW, Wegert K, Kuballa T, Schneider R, Ruge W, Reusch H, Alexy U, Kersting M, Winkler G: Caffeine intake from beverages in German children, adolescents, and adults. J Caffeine Res 2013, 3:47-53.
• [30]EFSA: Potential risks for public health due to the presence of nicotine in wild mushrooms EFSA J 2009, RN-286:1-47.
• [31]OECD SIDS: Glycerol CAS No: 56-81-5. UNEP Publications, Nairobi, Kenya; 2002.
• [32]JECFA: 1,2-Propylene glycol In WHO Food Additives Series 5. Toxicological Evaluation of Some Food Additives Including Anticaking Agents, Antimicrobials, Antioxidants, Emulsifiers, and Thickening Agents. World Health Organization, Geneva, Switzerland; 1974:275-277.
• [33]ATSDR: Toxicological Profile for Ethylene glycol. U.S. Department of Health and Human Services. Public Health Service. Agency for Toxic Substances and Disease Registry, Atlanta, Georgia; 2010.
• [34]EFSA Panel on Contaminants in the Food Chain: Scientific Opinion on the evaluation of the substances currently on the list in the annex to Commission Directive 96/3/EC as acceptable previous cargoes for edible fats and oils - Part III of III EFSA J 2012, 10:2984.
• [35]JECFA: Ethyl vanillin In WHO Food Additives Series 35. Toxicological Evaluation of Certain Food Additives and Contaminants. World Health Organization, Geneva, Switzerland; 1996:141-154.
• [36]Lachenmeier DW, Uebelacker M: Risk assessment of thujone in foods and medicines containing sage and wormwood - evidence for a need of regulatory changes? Regul Toxicol Pharmacol 2010, 58:437-443.
• [37]U.S.EPA: The Use of the Benchmark Dose Approach in Health Risk Assessment. EPA/630/R-94/007. Office of Research and Development. US Environmental Protection Agency, Washington, DC; 1995.
• [38]EFSA: Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic EFSA J 2005, 282:1-31.
• [39]Medeiros Vinci R, Jacxsens L, Van Loco J, Matsiko E, Lachat C, de Schaetzen T, Canfyn M, Van Overmeire I, Kolsteren P, De Meulenaer B: Assessment of human exposure to benzene through foods from the Belgian market. Chemosphere 2012, 88:1001-1007.
• [40]Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V: Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse 2013, 7:139-146.
• [41]EFSA Scientific Committee: Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data EFSA J 2012, 10:2579.
• [42]Lindgren M, Molander L, Verbaan C, Lunell E, Rosen I: Electroencephalographic effects of intravenous nicotine–a dose–response study. Psychopharmacol (Berl) 1999, 145:342-350.
• [43]Hine CH, Anderson HH, Moon HD, Dunlap MK, Morse MS: Comparative toxicity of synthetic and natural glycerin. AMA Arch Ind Hyg Occup Med 1953, 7:282-291.
• [44]Gaunt IF, Carpanini FM, Grasso P, Lansdown AB: Long-term toxicity of propylene glycol in rats. Food Cosmet Toxicol 1972, 10:151-162.
• [45]Weil CS, Woodside MD, Smyth HF Jr, Carpenter CP: Results of feeding propylene glycol in the diet to dogs for two years. Food Cosmet Toxicol 1971, 9:479-490.
• [46]Neeper-Bradley TL, Tyl RW, Fisher LC, Kubena MF, Vrbanic MA, Losco PE: Determination of a no-observed-effect level for developmental toxicity of ethylene glycol administered by gavage to CD rats and CD-1 mice. Fundam Appl Toxicol 1995, 27:121-130.
• [47]Tyl RW, Ballantyne B, France KA, Fisher LC, Klonne DR, Pritts IM: Evaluation of the developmental toxicity of ethylene glycol monohexyl ether vapor in Fischer 344 rats and New Zealand white rabbits. Fundam Appl Toxicol 1989, 12:269-280.
• [48]NTP: Toxicology and carcinogenesis studies of a,b-thujone (Cas No. 76231-76-0) in F344/N rats and B6C3F1 mice (gavage studies) Natl Toxicol Program Tech Rep Ser 2011, 570:1-260.
• [49]Westenberger BJ: Evaluation of E-cigarettes. DPATR-FY-09-23. FDA Department of Health & Human Services, St. Lous, MO; 2009.
• [50]Alliance Technologies: Chemical Composition of “Instead” Electronic Cigarette Smoke Juice and Vapour. Alliance Technologies, Monmouth Junction, NJ, USA; 2009.
• [51]Alliance Technologies: Characterization of Liquid “Smoke Juice” for Electronic Cigarettes. Alliance Technologies, Monmouth Junction, NJ, USA; 2009.
• [52]Monakhova YB, Tsikin AM, Kuballa T, Lachenmeier DW, Mushtakova SP: Independent component analysis (ICA) algorithms for improved spectral deconvolution of overlapped signals in 1H NMR analysis: application to foods and related products. Magn Reson Chem 2014, 52:231-240.
• [53]Lambe J: The use of food consumption data in assessments of exposure to food chemicals including the application of probabilistic modelling. Proc Nutr Soc 2002, 61:11-18.
• [54]Gibney MJ, van der Voet H: Introduction to the Monte Carlo project and the approach to the validation of probabilistic models of dietary exposure to selected food chemicals. Food Addit Contam 2003, 20(Suppl 1):S1-S7.
• [55]IPCS: Environmental Health Criteria 240: Principles and Methods for the Risk Assessment of Chemicals in Food. World Health Organization, Geneva; 2009.
• [56]Mayer B: How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol 2014, 88:5-7.
• [57]Ginzkey C, Kampfinger K, Friehs G, Kohler C, Hagen R, Richter E, Kleinsasser NH: Nicotine induces DNA damage in human salivary glands. Toxicol Lett 2009, 184:1-4.
• [58]Ginzkey C, Steussloff G, Koehler C, Hackenberg S, Richter E, Hagen R, Kleinsasser NH: Nicotine causes genotoxic damage but is not metabolized during long-term exposure of human nasal miniorgan cultures. Toxicol Lett 2014, 229:303-310.
• [59]Ginzkey C, Steussloff G, Koehler C, Burghartz M, Scherzed A, Hackenberg S, Hagen R, Kleinsasser NH: Nicotine derived genotoxic effects in human primary parotid gland cells as assessed in vitro by comet assay, cytokinesis-block micronucleus test and chromosome aberrations test. Toxicol In Vitro 2014, 28:838-846.
• [60]Catassi A, Servent D, Paleari L, Cesario A, Russo P: Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutat Res 2008, 659:221-231.
• [61]Schroeder MJ, Hoffman AC: Electronic cigarettes and nicotine clinical pharmacology. Tob Control 2014, 23(Suppl 2):ii30-ii35.
• [62]FDA: CFR - Code of Federal Regulations Title 21. Foods and Drugs. Chapter I. Subchapter B. Part 184 - Direct Food Substances Affirmed as Generally Recognized as Safe. U.S. Food and Drug Administration, Silver Spring, MD, USA; 2013.
• [63]Lachenmeier DW, Steffen C, El-Atma O, Maixner S, Löbell-Behrends S, Kohl-Himmelseher M: What is a food and what is a medicinal product in the European Union? Use of the benchmark dose (BMD) methodology to define a threshold for “pharmacological action”. Regul Toxicol Pharmacol 2012, 64:286-295.
• [64]European Commission: E-cigarettes myth buster. 2014 [http://ec.europa.eu/health/tobacco/docs/tobacco_mythbuster_en.pdf]
• [65]European Commission: E-cigarettes. 2014 [http://ec.europa.eu/health/tobacco/docs/fs_ecigarettes_en.pdf]